Related Experiment Video
Updated: Dec 13, 2025

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs
Weiwei Yang1, Xuran Li1, Xin Li1
1Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China; National Clinical Research Center for Geriatric Disorders, Beijing, China.
Abstract:
Hemoglobin (Hb) is the main component of red blood cells, and the majority of alpha-synuclein in the blood is present inside them. In Parkinson's disease and aging human brains, the levels of mitochondrial neuronal hemoglobin are significantly decreased in neurons where α-Syn has accumulated, suggesting a relationship between these two proteins. In the present study, we demonstrate that a complex comprising α-Syn and Hb exists in both peripheral RBCs and brain tissue in aging humans using Co-Immunoprecipitation and a newly established ELISA assay. The nHbα-Syn levels in the mitochondrial fraction of the human striatum reduced in an age-dependent manner which was negatively correlated with the nHbα-Syn complex levels in the cytoplasmic extraction. In contrast, no age-related alteration in the nHbα-Syn complex was found in the above subcellular fractions of the human cerebellum. Furthermore, the nHbα-Syn complex levels in RBCs increased with age, which agrees with the changes observed in the cytoplasm of the human striatum. Meanwhile, sequential window acquisition of all theoretical mass spectra-MS (SWATH-MS) was used to confirm the presence of the Hbα-Syn complex in RBCs and also found that nHbα-Syn levels increased notably in PD patients compared to healthy controls (HC). Receiver operating characteristic (ROC) curves indicated that Hbα-Syn in PD patients was distinct from HC, with areas under the curve (AUCs) of 0.875. The above results suggest that the alteration in nHbα-Syn levels in RBCs reflects those in select regions of the human brain, thereby providing a possibility of using Hbα-Syn as a biomarker to diagnose PD.

